Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Capital Expenditures (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed Capital Expenditures for 13 consecutive years, with $9.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Expenditures fell 56.28% year-over-year to $9.1 million, compared with a TTM value of $49.7 million through Sep 2025, down 49.91%, and an annual FY2024 reading of $86.3 million, down 50.84% over the prior year.
  • Capital Expenditures was $9.1 million for Q3 2025 at Aspen Aerogels, down from $12.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $67.0 million in Q3 2022 and bottomed at $1.5 million in Q1 2021.
  • Average Capital Expenditures over 5 years is $25.7 million, with a median of $20.8 million recorded in 2024.
  • The sharpest move saw Capital Expenditures soared 2872.01% in 2022, then crashed 62.39% in 2024.
  • Year by year, Capital Expenditures stood at $7.6 million in 2021, then skyrocketed by 666.85% to $58.6 million in 2022, then tumbled by 52.6% to $27.8 million in 2023, then crashed by 46.91% to $14.8 million in 2024, then plummeted by 38.3% to $9.1 million in 2025.
  • Business Quant data shows Capital Expenditures for ASPN at $9.1 million in Q3 2025, $12.9 million in Q2 2025, and $13.0 million in Q1 2025.